Head and Neck Cancer Management

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Head and Neck Cancer (HNC) is a broad category of cancer, comprises of cancer that origin into oral cavity, pharynx, larynx, sinuses and salivary gland. Majority of oral cancer cases reported in Pakistan are metastatic to Head and Neck and are with morphology of squamous cell carcinoma. Locally advance, un-resectable tumors are treated with systemic therapies. Commonly prescribe systemic therapies includes chemotherapy and targeted therapy. However, chemotherapy is the most prescribed systemic therapy because of advance presentation of cases with the morphology of Squamous cell carcinoma. Cisplatin and Carboplatin are drug of choice in HNC treatment. Chemotherapy treatment result in many toxicities such as nausea-vomiting, nephrotoxicity, cystitis, diarrhea, mucositis, ototoxicity, myelosuppresion, allergic reaction and others. These side-effects could be overcome through pharmacological and non-pharmacological interventions.

Cite

CITATION STYLE

APA

Shams, S. (2023). Head and Neck Cancer Management. Asian Pacific Journal of Cancer Care. West Asia Organization for Cancer Prevention. https://doi.org/10.31557/apjcc.2023.8.1.263-265

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free